Pharmacoscopy for Patients With Refractory Primary Brain Tumors

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 12, 2026

Primary Completion Date

September 15, 2028

Study Completion Date

September 15, 2028

Conditions
Brain (Nervous System) CancersGlioblastomaGliomaEpendymomaMedulloblastomaMeningiomaRare Primary Brain TumorsRare CNS Primary Tumors
Interventions
DEVICE

Pharmacoscopy 1.0

The intervention is the submission of freshly obtained surgical material to ex vivo drug profiling which we term pharmacoscopy (PCY). The performance study is interventional as the test results shall influence patient management decisions and/or may be used to guide treatment.

Trial Locations (3)

4021

University Hospital Basel, Basel

8091

University Hospital Zurich, Zurich

9007

Cantonal Hospital St Gallen, Sankt Gallen

All Listed Sponsors
collaborator

University Hospital, Zürich

OTHER

collaborator

University Hospital, Basel, Switzerland

OTHER

collaborator

Cantonal Hospital St. Gallen, Switzerland

UNKNOWN

lead

University of Zurich

OTHER